Newsroom
Sorted by: Latest
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 27.04.2026 FTAI IE000YIQZ0H6 200,002.00 USD 5,285,795.18 26.429 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 27.04.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,775,597.01 25.170 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 27.04.2026 QDEC.LN IE000GAKWFA7 450,002.00 USD 10,641,179.13 23.647 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Europe Infrastructure UCITS ETF 27.04.2026 FTEI.LN IE000TIZ5AP4 200,002.00 EUR 4,208,509.48 21.042 ...
-
EVelution Energy Secures $850 million Cobalt Offtake Agreement with Mitsui, Advancing U.S. and Allied Critical Minerals Independence
YUMA, Ariz.--(BUSINESS WIRE)--EVelution Energy LLC (“EVelution Energy” or the “Company”), a U.S. critical minerals company developing the first commercial-scale cobalt metal and cobalt sulfate processing facility in the United States, today announced the signing of a binding long-term offtake agreement with Mitsui & Co., Ltd. (“Mitsui”; Head Office: Tokyo; President and CEO: Kenichi Hori), valued at approximately $850 million over the five-year term of the agreement (based on current market...
-
Alan Draper Named Chief Executive Officer of Nippon Sanso Matheson
IRVING, Texas--(BUSINESS WIRE)--Nippon Sanso Matheson, Inc. announced that Alan Draper assumed the role of Chief Executive Officer effective April 1, 2026. A thirty-year industry veteran, Draper will lead Nippon Sanso Matheson’s U.S.-based business, which includes more than 300 locations nationwide and over 40 air separation units serving customers coast to coast. Draper assumes this role following a distinguished global career spanning nearly three decades in the industrial gases industry. He...
-
lululemon Announces Appointment of Esi Eggleston Bracey to Board of Directors
VANCOUVER, British Columbia--(BUSINESS WIRE)--lululemon athletica inc. (NASDAQ:LULU) today announced the appointment of Esi Eggleston Bracey, former Chief Growth & Marketing Officer of Unilever PLC, to its Board of Directors, effective immediately. With Ms. Bracey joining the Board, the company will have appointed six new independent directors in the last five years as part of the Board’s commitment to continued refreshment. “Esi is a seasoned consumer and beauty industry executive whose ca...
-
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced an upcoming poster presentation that will demystify the intracerebroventricular (ICV) route of administration as a well-established, routinely performed neurosurgical procedure and a deliberate delivery strategy designed to maximize efficacy for central nervous system (CNS) gene therap...
-
Superior Health Holdings Acquires Compassion Homecare and Sans Bois Hospice, Expanding into Oklahoma
METAIRIE, La. & STIGLER, Okla.--(BUSINESS WIRE)--Superior Health Holdings ("Superior"), a portfolio company of Renovus Capital Partners, today announced the acquisition of Chant Healthcare ("Chant"), a leading provider of home health, homecare, and hospice services headquartered in Southeastern Oklahoma operating through two core entities — Compassion Home Care, which provides home health and homecare services, and Sans Bois Hospice. The transaction marks Superior's entry into Oklahoma with ser...